维普期刊资源整合服务平台（V6.5）

51篇 您的检索式：作者名="Ossenkoppele GJ"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	High-Dose daunorubicin in older patients with acute myeloid leukemia显示文摘	Lowenberg B Ossenkoppele GJ van Putten W	2009	N Engl J Med2009，361，13：	1
2	MRD in AML: it is time to change the definition of remission 显示文摘	Ossenkoppele GJ Schuurhuis GJ	2014	Best practice & research Clinical haematology2014，27，34：	1
3	Diagnosis and management of acute myeloid leukemia in adults:recommendations from an international expert panel,on behalf of the European LeukemiaNet显示文摘	Dhner H Estey EH Amadori S Appelbaum FR Büchner T Burnett AK Dombret H Fenaux P Grimwade D Larson RA Lo-Coco F Naoe T Niederwieser D Ossenkoppele GJ Sanz MA Sierra J Tallman MS Lwenberg B Bloomfield CD	2010	{H}Blood2010，，03：	1
4	MHC class Ⅱ molecules in tumour immunology: prognostic marker and target for immune modulation 显示文摘	Chamuleau ME Ossenkoppele GJ van de Loosdrecht AA	2006	Immunobiology2006，211，68：	1
5	ALK expression in extranodal anaplastic large cell lymphoma favors systemic diseasewith (primary) nodal involvement and a good prognosis and occurs before dissemination显示文摘	Berge RL Oudejans JJ Ossenkoppele GJ	2000	J Clin Pathol2000，53，：	1
6	The value of fludarabine in addition to ARA-C and G-CSF in the trearment of patients with high-risk myelodyspalsic syndromes and AML in elderly patients显示文摘	Ossenkoppele GJ Graveland WJ Sonneveld P		0，，08：	1
7	The value of fludarabine in addition to ARA-C and G-CSF in the treatment of pations with high-risk myelodyspastic syndromes and AML in elderly patients显示文摘	Ossenkoppele GJ Graveland WJ Sonneveld P	2004	Blood2004，103，8：	1
8	High-dosedaunorubicin in older patients with acute myeloid leukemia显示文摘	Lowenberg B Ossenkoppele GJ van Putten W	2009	NEngl J Med’2009，361，13：	1
9	ALK expression in extranodal anaplastic large cell lymphoma favours systemic disease with (primary) nodal involvement and a good prognosis and occurs before dissemination显示文摘	ten Berge RL Oudejans JJ Ossenkoppele GJ		0，，06：	1
10	High-dose daunorubicin in older patients with acute myeloid leukemia显示文摘	Lwenberg B Ossenkoppele GJ van Putten W	2009	N Engl J Med2009，361，：	1
11	The value of fludarabine in addition to ARA-C and G-CSF in the treatment of patients with high-risk myelodysplastic syndromes and AML in elderly patients显示文摘	Ossenkoppele GJ Graveland WJ Sonneveld P	2004	Blood2004，103，8：	1
12	Feasibility of clinical dendritic cell vaccination in acute myeloid leukemia显示文摘	Houtenbos I Westers TM Ossenkoppele GJ	2006	Immunobiology2006，211，68：	1
13	MHC class II molecules in tumour immunology: prognostic marker and target for immune modulation显示文摘	Chamuleau ME Ossenkoppele GJ van de Loosdrecht AA	2006	Immunobiology2006，211，68：	1
14	MHC class II molecules in tumour immunology: prognostic marker and target for immune modulation 显示文摘	Chamulean ME Ossenkoppele GJ van de Loosdrecht AA	2006	Immunobiology2006，211，6：	1
15	High-dose dauno- rubicin in older patients with acute myeloid leukemia显示文摘	Lowenberg B Ossenkoppele GJ Van Putten WA	2009	N Engl J Med2009，361，13：	1
16	ALK expression in extranodal anaplastie large cell lymphoma favours systemic disease with (primary) nodal involvement and a good prognosis and occurs before dissemination显示文摘	Ten Berge RL Oudejans JJ Ossenkoppele GJ	2000	J Clin Pathol2000，53，6：	1
17	ALK-negative systemic anaplastic large cell lymphoma:differential diagnostic and prognostic aspects:a review显示文摘	Berge RL Oudejans JJ Ossenkoppele GJ	2003	J Pathol2003，200，：	1
18	Vaccination of chronic myeloid leukemia patients with autologous in vitro cultured leukemic dendritic cells显示文摘	Ossenkoppele GJ Stam AG Westers TM	2003	Leukemia2003，17，7：	1
19	New insights into thepathogenesis of chronic myeloid leukaemia : towards a path to cure 显示文摘	Thielen N Ossenkoppele GJ Schuurhuis GJ	2011	Neth J Med2011，69，10：	1
20	High-dose daunorubicin in older patients with Acute Myeloid Leukemia显示文摘	L(o)wenberg B Ossenkoppele GJ van Putten W	2009	N Engl J Med2009，361，13：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示